Adolescent Trial for Plaque Psoriasis (41-145 Weeks)

Adolescents aged 12 to under 18 years old with a diagnosis of moderate to severe plaque psoriasis for at least 3 months, may qualify to participate. Teens must have psoriatic involvement of 10% or more body surface area and weigh 30 kg or more. They must also be a candidate for systemic psoriasis therapy and/or photo/chemotherapy.

Participants will receive one of two doses of investigational medication (active study drug), via subcutaneous injection. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Length of study participation may vary. If eligible to enter the open-label extension period, participation may last up to 145 weeks and involve about 35 visits to the study centre. If only the initial treatment period is completed, participation will last up to 41 weeks and include 9 visits.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more